Dernaika Fouad, Halawy Layal, Zeaiter Joseph, Kawrani Sara, Mroue Dima, Lteif Anthony, Kourani Sima, Mehanna Mohamed, Abboud Celine, Mroueh Mohamad, Milane Aline
Department of Pharmaceutical Sciences, School of Pharmacy, Lebanese American University, Byblos, Lebanon.
Bahaa and Walid Bassatne Department of Chemical Engineering and Advanced Energy, Maroun Semaan Faculty of Engineering and Architecture, American University of Beirut, Lebanon.
Heliyon. 2024 Sep 3;10(17):e37373. doi: 10.1016/j.heliyon.2024.e37373. eCollection 2024 Sep 15.
The growing interest in the therapeutic potential of cannabidiol (CBD) has led to the need for effective and reliable delivery methods that overcome its low oral absorption. Zeolites, a class of porous nanoparticles, offer unique advantages as drug carriers due to their high surface area and adjustable pore size. In this study, a zeolite-based drug delivery system was developed for the encapsulation of CBD. The zeolite particles were characterized using various techniques such as Scanning Electron Microscopy (SEM), N adsorption analysis, Solid-state Fourier Transform Infrared (FTIR), Direct Light Scattering (DLS), X-ray diffraction (XRD) and thermogravimetric analysis (TGA) before and after the loading. The drug encapsulation efficiency, and the release profile of CBD from the zeolite matrix were evaluated in addition to dissolution experiments in the intestinal and gastric simulated fluids. The results showed that the loaded zeolite particles exhibited high encapsulation efficiency of 73.5 %. XRD analysis proved that the USY structure remained intact after loading with CBD. DLS and N adsorption analysis indicated that CBD was successfully loaded into the zeolite matrix. When compared to CBD containing particles in a commercialized capsule, the in-vitro dissolution rate of CBD loaded zeolite was significantly higher after 30 min in the simulated stomach (pH 1.8) and the intestinal (pH 6.8) fluids, 67.8 % versus 43.6 % and 62.6 % vs 38.4 % respectively. Our findings open new avenues for the use of zeolites as an efficient drug delivery system for drugs with low bioavailability like CBD.
对大麻二酚(CBD)治疗潜力的兴趣日益增长,这就需要有效且可靠的给药方法来克服其口服吸收低的问题。沸石是一类多孔纳米颗粒,由于其高比表面积和可调节的孔径,作为药物载体具有独特优势。在本研究中,开发了一种基于沸石的药物递送系统用于包封CBD。在负载前后,使用扫描电子显微镜(SEM)、N吸附分析、固态傅里叶变换红外光谱(FTIR)、直接光散射(DLS)、X射线衍射(XRD)和热重分析(TGA)等各种技术对沸石颗粒进行表征。除了在肠道和胃模拟液中的溶解实验外,还评估了药物包封效率以及CBD从沸石基质中的释放曲线。结果表明,负载的沸石颗粒表现出73.5%的高包封效率。XRD分析证明,负载CBD后USY结构保持完整。DLS和N吸附分析表明CBD成功负载到沸石基质中。与商业化胶囊中含CBD的颗粒相比,负载CBD的沸石在模拟胃(pH 1.8)和肠道(pH 6.8)液中30分钟后的体外溶解速率显著更高,分别为67.8%对43.6%和62.6%对38.4%。我们的研究结果为将沸石用作像CBD这样生物利用度低的药物的高效药物递送系统开辟了新途径。